CELL INTELLIGENCE · 肿瘤细胞治疗研究

使用第二近红外共轭寡电解质探针的过继免疫细胞分布与扩增超灵敏体内成像

Ultrasensitive In Vivo Imaging of Adoptive Immune Cell Distribution and Expansion Using Second Near-Infrared Conjugated Oligoelectrolyte Probes.

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

靶向 COX-2/PGE(2) 轴增强脑肿瘤中 NK 和 T 细胞免疫治疗

Targeting the COX-2/PGE(2) axis to enhance NK and T cell immunotherapy in brain tumors.

靶向 PSMD14-BCKDK 通路克服免疫抑制并增强 CAR-NK 在胶质母细胞瘤中的浸润

Targeting the PSMD14-BCKDK pathway overcomes immune suppression and enhances CAR-NK infiltration in glioblastoma.

胶质瘤中的肠-脑-免疫轴：新兴机制与治疗机遇

The Gut-Brain-Immune Axis in Glioma: Emerging Mechanisms and Therapeutic Opportunities.

细胞毒性淋巴细胞介导肿瘤杀伤相关基因的整合分析揭示 LDHA 为新型胶质母细胞瘤治疗靶点

Integrative Analysis of Cytotoxic Lymphocytes-Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target.

免疫治疗在胶质母细胞瘤中的应用价值与研究前沿：文献计量学与可视化分析

Application Value and Research Frontiers of Immunotherapy in Glioblastoma: A Bibliometric and Visualized Analysis.

过去数十年间，人们对 GBM 免疫治疗的兴趣日益增长。

超越 CAR-T 细胞：探索 CAR-NK、CAR-M 与 CAR-γδ T 策略在实体瘤免疫治疗中的应用

Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T strategies in solid tumor immunotherapy.

从实验台到临床：实体恶性肿瘤 CAR-T 细胞治疗的新兴范式

From Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.

靶向 CSPG4 增强 CAR-NK 细胞对胶质母细胞瘤的抗肿瘤活性

Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma.

靶向 CSPG4 的 CAR-NK 细胞表现出强效的抗 GBM 活性，凸显其作为新型免疫疗法的潜力。这些发现为推进 CSPG4 导向的 CAR-NK 细胞疗法进入临床试验提供了坚实的临床前基础，回应了 GBM 治疗中对有效疗法的迫切需求。